MedPath
HSA Approval

LORFAST TABLET 10 mg

SIN11679P

LORFAST TABLET 10 mg

LORFAST TABLET 10 mg

September 24, 2001

UNI DRUG HOUSE

UNI DRUG HOUSE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNI DRUG HOUSE
Licence HolderUNI DRUG HOUSE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AX13

loratadine

Manufacturer Information

UNI DRUG HOUSE SDN. BHD.

CADILA PHARMACEUTICALS LTD

Active Ingredients

LORATADINE

10 mg

Loratadine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LORFAST TABLET 10 mg - HSA Approval | MedPath